Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and Equipment
Growth Metrics
Income Statement
Others
Ratios

SBC Medical Group Holdings (SBCWW) Depreciation & Amortization (CF) (2023 - 2025)

Historic Depreciation & Amortization (CF) for SBC Medical Group Holdings (SBCWW) over the last 3 years, with Q3 2025 value amounting to $746211.0.

  • SBC Medical Group Holdings' Depreciation & Amortization (CF) fell 2672.42% to $746211.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year decrease of 4577.65%. This contributed to the annual value of $3.8 million for FY2024, which is 6897.69% down from last year.
  • Latest data reveals that SBC Medical Group Holdings reported Depreciation & Amortization (CF) of $746211.0 as of Q3 2025, which was down 2672.42% from $636101.0 recorded in Q2 2025.
  • SBC Medical Group Holdings' Depreciation & Amortization (CF)'s 5-year high stood at $2.6 million during Q4 2023, with a 5-year trough of $628304.0 in Q1 2025.
  • For the 3-year period, SBC Medical Group Holdings' Depreciation & Amortization (CF) averaged around $1.1 million, with its median value being $931596.0 (2024).
  • As far as peak fluctuations go, SBC Medical Group Holdings' Depreciation & Amortization (CF) plummeted by 6358.54% in 2024, and later crashed by 2344.85% in 2025.
  • SBC Medical Group Holdings' Depreciation & Amortization (CF) (Quarter) stood at $2.6 million in 2023, then crashed by 63.59% to $931596.0 in 2024, then decreased by 19.9% to $746211.0 in 2025.
  • Its Depreciation & Amortization (CF) stands at $746211.0 for Q3 2025, versus $636101.0 for Q2 2025 and $628304.0 for Q1 2025.